SVB Wealth LLC Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

SVB Wealth LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 23,373 shares of the financial services provider’s stock, valued at approximately $3,090,000.

Other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at $29,000. HHM Wealth Advisors LLC raised its holdings in iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at about $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at about $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $137.03 on Friday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The firm has a market capitalization of $6.33 billion, a P/E ratio of 24.52 and a beta of 0.77. The company’s 50 day simple moving average is $135.91 and its 200 day simple moving average is $140.62.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.